Advancing Mental Health Parity: Exploring How Increased Global Investment in Treatment Options Bolsters the Venlafaxine Market's Growth to $5.20B
The significant projected growth of the Venlafaxine market to $5.20 billion by 2035 is fundamentally underpinned by the global movement toward advancing mental health parity—the principle that mental health conditions should be treated and funded equally to physical health conditions. As nations and healthcare systems worldwide increase their investment in mental health infrastructure,...
0 Yorumlar
0 hisse senetleri
275 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt